{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:36:16Z","timestamp":1777091776586,"version":"3.51.4"},"reference-count":36,"publisher":"Tech Science Press","issue":"6","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":143,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2024]]},"DOI":"10.32604\/or.2024.045025","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T07:37:12Z","timestamp":1707205032000},"page":"1119-1128","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling"],"prefix":"10.32604","volume":"32","author":[{"given":"YUE","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WENYU","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOWANG","family":"HAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUE","family":"QIAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAITAO","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIANYING","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEN-BIN","family":"OU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JTO.0b013e3181c5920c","article-title":"Trends in stage distribution for patients with non-small cell lung cancer: A national cancer database survey","volume":"5","author":"Morgensztern","year":"2010","journal-title":"Journal of Thoracic Oncology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00292-014-1974-3","article-title":"The 2015 WHO classification of lung tumors","volume":"35","author":"Travis","year":"2014","journal-title":"Der Pathologe"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.3390\/ijms22147416","article-title":"The updating of biological functions of methyltransferase SETDB1 and its relevance in lung cancer and mesothelioma","volume":"22","author":"Yuan","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.21037\/tlcr.2020.01.09","article-title":"Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer","volume":"9","author":"Zhu","year":"2020","journal-title":"Translational Lung Cancer Research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06030","article-title":"LKB1 modulates lung cancer differentiation and metastasis","volume":"448","author":"Ji","year":"2007","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","year":"2012","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00432-018-2727-0","article-title":"The hippo pathway provides novel insights into lung cancer and mesothelioma treatment","volume":"144","author":"Liu","year":"2018","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/annonc\/mdx017","article-title":"Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA","volume":"28","author":"Remon","year":"2017","journal-title":"Annals of Oncology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1158\/2159-8290.CD-15-0399","article-title":"Heterogeneity underlies the emergence of EGFRT790 wild-type clones following treatment of T790M-positive cancers with a third-generation EGFR inhibitor","volume":"5","author":"Piotrowska","year":"2015","journal-title":"Cancer Discovery"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: Current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Research"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/srep03574","article-title":"HE4 (WFDC2) gene overexpression promotes ovarian tumor growth","volume":"4","author":"Moore","year":"2014","journal-title":"Scientific Reports"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e68994","DOI":"10.1371\/journal.pone.0068994","article-title":"Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma","volume":"8","author":"Zhuang","year":"2013","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.7150\/jca.57880","article-title":"WFDC protein: A promising diagnosis biomarker of ovarian cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Journal of Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4149\/neo_2018_181212N961","article-title":"The value of human epididymis protein 4 (HE4) as a serum tumor marker for accurate bone metastases finding by whole-body bone scintigraphy in lung cancer patients","volume":"66","author":"Weissensteiner","year":"2019","journal-title":"Neoplasma"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.31557\/APJCP.2019.20.8.2405","article-title":"The application value of serum HE4 in the diagnosis of lung cancer","volume":"20","author":"Wang","year":"2019","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/diagnostics11071274","article-title":"HE4 in the diagnostic approach of endometrial cancer in patients with postmenopausal bleeding, the METRODEC protocol: Protocol for a multicenter prospective study","volume":"11","author":"Degez","year":"2021","journal-title":"Diagnostics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2509\u20132507","DOI":"10.31557\/APJCP.2021.22.8.2509","article-title":"Serum human epididymis protein-4 (HE4)\u2014A novel approach to differentiate malignant Frombenign Breast tumors","volume":"22","author":"Sai Baba","year":"2021","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/IGC.0000000000000078","article-title":"Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase\/AKT pathways","volume":"24","author":"Kong","year":"2014","journal-title":"International Journal of Gynecological Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"bio043570","DOI":"10.1242\/bio.043570","article-title":"Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK\/STAT3 pathway","volume":"8","author":"Wang","year":"2019","journal-title":"Biology Open"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12935-021-01989-7","article-title":"YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K\/AKT and MAPK pathways","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell International"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13046-020-01770-0","article-title":"ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15","volume":"39","author":"Wang","year":"2020","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12935-019-0864-4","article-title":"Interaction of HE4 and ANXA2 exists in various malignant cells-HE4-ANXA2-MMP2 protein complex promotes cell migration","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell International"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cca.2017.05.007","article-title":"HE4 expression in lung cancer, a meta-analysis","volume":"470","author":"Zhong","year":"2017","journal-title":"Clinica Chimica Acta"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer","volume":"33","author":"Iwahori","year":"2012","journal-title":"Tumor Biology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respiratory Research"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1038\/s41388-019-0894-3","article-title":"Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence","volume":"38","author":"Ou","year":"2019","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41416-023-02330-x","article-title":"SETDB1 tumor suppressor roles in near-haploid mesothelioma involve TP53","volume":"129","author":"Xu","year":"2023","journal-title":"British Journal of Cancer"},{"key":"ref33","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin","year":"2001","journal-title":"Cancer Research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41419-020-02752-y","article-title":"WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation","volume":"11","author":"Xiong","year":"2020","journal-title":"Cell Death & Disease"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biochi.2014.06.022","article-title":"Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells","volume":"105","author":"Zhuang","year":"2014","journal-title":"Biochimie"},{"key":"ref36","first-page":"833","article-title":"Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway","volume":"23","author":"Liu","year":"2010","journal-title":"Oncology Reports"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2024\/TSP_OR-32-6\/OncolRes-32-06-45025\/OncolRes-32-45025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T09:19:57Z","timestamp":1741252797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v32n6\/56593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.045025","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"2023-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-23","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}